Investors Profit From Phathom Pharmaceuticals Inc (NASDAQ: PHAT) -13.04% Loss
Phathom Pharmaceuticals Inc (NASDAQ:PHAT) traded at $4.40 at close of the session on Monday, March 10 and made a downward move of -13.04% on its previous day’s price. Phathom Pharmaceuticals Inc has a market cap of $306.40 million and is expected to release its quarterly